These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8920174)

  • 1. Cognition enhancers in age-related cognitive decline.
    Riedel WJ; Jolles J
    Drugs Aging; 1996 Apr; 8(4):245-74. PubMed ID: 8920174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline in ageing: are AAMI and AACD distinct entities?
    Richards M; Touchon J; Ledesert B; Richie K
    Int J Geriatr Psychiatry; 1999 Jul; 14(7):534-40. PubMed ID: 10440973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Liu G; Weinger JG; Lu ZL; Xue F; Sadeghpour S
    J Alzheimers Dis; 2016; 49(4):971-90. PubMed ID: 26519439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease.
    Robbins TW; McAlonan G; Muir JL; Everitt BJ
    Behav Brain Res; 1997 Feb; 83(1-2):15-23. PubMed ID: 9062655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine provocation-based pharmacological MRI model for testing procognitive agents.
    Hegedűs N; Laszy J; Gyertyán I; Kocsis P; Gajári D; Dávid S; Deli L; Pozsgay Z; Tihanyi K
    J Psychopharmacol; 2015 Apr; 29(4):447-55. PubMed ID: 25586394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancers: molecules, mechanisms and minds.
    Frenguelli BG
    Neuropharmacology; 2013 Jan; 64():1. PubMed ID: 22985720
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging cognitive enhancing drugs.
    Buccafusco JJ
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):577-89. PubMed ID: 19772371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mind Bending Quest for Cognitive Enhancers.
    Arce E; Ehlers MD
    Clin Pharmacol Ther; 2017 Feb; 101(2):179-181. PubMed ID: 27706806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition Enhancing Activity of Sulforaphane Against Scopolamine Induced Cognitive Impairment in Zebra Fish (Danio rerio).
    Rajesh V; Ilanthalir S
    Neurochem Res; 2016 Oct; 41(10):2538-2548. PubMed ID: 27255600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AVCRI104P3, a novel multitarget compound with cognition-enhancing and anxiolytic activities: studies in cognitively poor middle-aged mice.
    Giménez-Llort L; Ratia M; Pérez B; Camps P; Muñoz-Torrero D; Badia A; Clos MV
    Behav Brain Res; 2015 Jun; 286():97-103. PubMed ID: 25732954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin and cognitive function in the elderly. Results of the PROSPER study.
    Trompet S; van Vliet P; de Craen AJ; Jolles J; Buckley BM; Murphy MB; Ford I; Macfarlane PW; Sattar N; Packard CJ; Stott DJ; Shepherd J; Bollen EL; Blauw GJ; Jukema JW; Westendorp RG
    J Neurol; 2010 Jan; 257(1):85-90. PubMed ID: 19653027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nootropes (cognition enhancers) and neuroprotectors].
    Vornin TA; Seredenin SB
    Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experts urge smart thinking on cognitive enhancers.
    Morris K
    Lancet Neurol; 2008 Jun; 7(6):476-7. PubMed ID: 18485312
    [No Abstract]   [Full Text] [Related]  

  • 17. Signaling pathways relevant to cognition-enhancing drug targets.
    Ménard C; Gaudreau P; Quirion R
    Handb Exp Pharmacol; 2015; 228():59-98. PubMed ID: 25977080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPA receptor potentiators as cognitive enhancers.
    O'Neill MJ; Dix S
    IDrugs; 2007 Mar; 10(3):185-92. PubMed ID: 17351873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese herbal medicine for Mild Cognitive Impairment and Age Associated Memory Impairment: a review of randomised controlled trials.
    May BH; Yang AW; Zhang AL; Owens MD; Bennett L; Head R; Cobiac L; Li CG; Hugel H; Story DF; Xue CC
    Biogerontology; 2009 Apr; 10(2):109-23. PubMed ID: 18716893
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.